Latest filings (excl ownership)
6-K
Results of the Annual General Meeting 2024
10 Jun 24
6-K
Current report (foreign)
22 May 24
NT 20-F
Notice of late annual filing (foreign)
30 Apr 24
6-K
Current report (foreign)
24 Apr 24
6-K
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
23 Apr 24
6-K
Current report (foreign)
8 Apr 24
6-K
Evotec announces CEO transition
3 Jan 24
6-K
Current report (foreign)
8 Nov 23
6-K
I. Management Report
29 Aug 23
6-K
Evotec provides update on financial impact of cyber-attack
27 Jul 23
6-K
Current report (foreign)
21 Jun 23
6-K
Current report (foreign)
20 Jun 23
S-8
Registration of securities for employees
30 May 23
6-K
Current report (foreign)
15 May 23
20-F
2022 FY
Annual report (foreign)
12 May 23
6-K
Current report (foreign)
12 May 23
6-K
Just – Evotec Biologics enters strategic biosimilars partnership with Sandoz
9 May 23
NT 20-F
Notice of late annual filing (foreign)
2 May 23
6-K
Current report (foreign)
7 Apr 23
6-K
Current report (foreign)
5 Apr 23
6-K
Current report (foreign)
28 Mar 23
6-K
Evotec and Bristol Myers Squibb expand strategic neurodegeneration partnership
28 Mar 23
6-K
Current report (foreign)
7 Feb 23
6-K
Current report (foreign)
16 Nov 22
6-K
Current report (foreign)
9 Nov 22
6-K
Current report (foreign)
6 Oct 22
6-K
I. Management Report
11 Aug 22
6-K
Current report (foreign)
24 Jun 22
6-K
Evotec SE reports results of Annual General Meeting 2022
23 Jun 22
6-K
Current report (foreign)
9 Jun 22
6-K
Current report (foreign)
7 Jun 22
6-K
Current report (foreign)
3 Jun 22
6-K
Current report (foreign)
11 May 22
6-K
Evotec and Bristol Myers Squibb extend and expand strategic partnership
10 May 22
20-F
2021 FY
Annual report (foreign)
26 Apr 22
6-K
Current report (foreign)
12 Apr 22
6-K
Current report (foreign)
4 Feb 22
6-K
Current report (foreign)
12 Nov 21
S-8
Registration of securities for employees
9 Nov 21
424B4
Prospectus supplement with pricing info
5 Nov 21